Company Contact: R.M. (Ric) Rumble, President and CEO, 418 651-0003, Email: info@tso3.com; Investor Relations: Chris Tyson, Liolios Group, Inc., 949 574-3860, TOS@liolios.comCopyright CNW Group 2015
TSO3 Engages Liolios Group to Lead New Strategic Investor Relations Program
View original source (CNW)TSO3 Inc on 6ix
Earlier from TSO3
- TSO3 to Enhance Canadian STERIZONE® Sterilizer - An Advanced Single Cycle to be Offered to Canadian Hospitals
- TSO3 announces financial results for second quarter 2015
- Mr. W. Barry McDonald resigns from TSO3 Board of Directors
- TSO3: Q2 2015 Financial Results Conference Call
- TSO3 pursuing extended claims for the STERIZONE® sterilization system
Later from TSO3
- TSO3: Q3 2015 Financial Results Conference Call
- TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 Sterilizer
- TSO3 Reports Third Quarter 2015 Financial Results
- TSO3 Appoints Steve West to Board of Directors
- TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
Follow TSO3 into a list and get an email when it puts out news.
Follow TSO3